APO Research
Talk to an analyst

APO RESEARCH · REPORT

Circadian Rhythm Sleep Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Circadian Rhythm Sleep Treatment Market Outlook and Growth Opportunities 2026

29 December 2025190 pages

Choose your research edition.

Industry ResearchCircadian Rhythm Sleep Treatment Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Circadian Rhythm Sleep Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Circadian Rhythm Sleep Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Circadian Rhythm Sleep Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Circadian Rhythm Sleep Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Circadian Rhythm Sleep Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Circadian Rhythm Sleep Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Circadian Rhythm Sleep Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Circadian Rhythm Sleep Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Circadian Rhythm Sleep Treatment market include By-Health, GNC, Jameison, Koninklijke Philips, Luminette, Natrol, Nature Made (Pharmavite), NBTY and PEGASI, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Circadian Rhythm Sleep Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Circadian Rhythm Sleep Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Circadian Rhythm Sleep Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Circadian Rhythm Sleep Treatment market.

Circadian Rhythm Sleep Treatment Segment by Company

By-Health

GNC

Jameison

Koninklijke Philips

Luminette

Natrol

Nature Made (Pharmavite)

NBTY

PEGASI

Sleepace

Takeda Pharmaceutical

Vicks (Procter & Gamble)

Teva Pharmaceuticals

Circadian Rhythm Sleep Treatment Segment by Type

Drug Therapy

Light Therapy

Circadian Rhythm Sleep Treatment Segment by Application

Delayed Sleep Phase Syndrome (DSPS)

Advanced Sleep Phase Syndrome (ASPS)

Irregular Sleep-Wake Disorder (ISWD)

Others

Circadian Rhythm Sleep Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Circadian Rhythm Sleep Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Circadian Rhythm Sleep Treatment key companies, revenue, market share, and recent developments.

3. To split the Circadian Rhythm Sleep Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Circadian Rhythm Sleep Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Circadian Rhythm Sleep Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Circadian Rhythm Sleep Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circadian Rhythm Sleep Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Circadian Rhythm Sleep Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circadian Rhythm Sleep Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Circadian Rhythm Sleep Treatment industry.

Chapter 3: Detailed analysis of Circadian Rhythm Sleep Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Circadian Rhythm Sleep Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Circadian Rhythm Sleep Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Circadian Rhythm Sleep Treatment Industry Trends Table 2. Circadian Rhythm Sleep Treatment Industry Drivers Table 3. Circadian Rhythm Sleep Treatment Industry Opportunities and Challenges Table 4. Circadian Rhythm Sleep Treatment Industry Restraints Table 5. Global Circadian Rhythm Sleep Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Circadian Rhythm Sleep Treatment Revenue Share by Company (2021-2026) Table 7. Global Circadian Rhythm Sleep Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Circadian Rhythm Sleep Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Circadian Rhythm Sleep Treatment Company, Product Type & Application Table 10. Global Circadian Rhythm Sleep Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Circadian Rhythm Sleep Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Drug Therapy Table 15. Significant Companies of Light Therapy Table 16. Global Circadian Rhythm Sleep Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Circadian Rhythm Sleep Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Circadian Rhythm Sleep Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Circadian Rhythm Sleep Treatment Sales Value Share by Type (2021-2026) Table 20. Global Circadian Rhythm Sleep Treatment Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Delayed Sleep Phase Syndrome (DSPS) Table 22. Significant Companies of Advanced Sleep Phase Syndrome (ASPS) Table 23. Significant Companies of Irregular Sleep-Wake Disorder (ISWD) Table 24. Significant Companies of Others Table 25. Global Circadian Rhythm Sleep Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Circadian Rhythm Sleep Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Circadian Rhythm Sleep Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Circadian Rhythm Sleep Treatment Sales Value Share by Application (2021-2026) Table 29. Global Circadian Rhythm Sleep Treatment Sales Value Share by Application (2027-2032) Table 30. Global Circadian Rhythm Sleep Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Circadian Rhythm Sleep Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Circadian Rhythm Sleep Treatment Sales Value Share by Region (2021-2026) Table 33. Global Circadian Rhythm Sleep Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Circadian Rhythm Sleep Treatment Sales Value Share by Region (2027-2032) Table 35. Global Circadian Rhythm Sleep Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Circadian Rhythm Sleep Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Circadian Rhythm Sleep Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global Circadian Rhythm Sleep Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Circadian Rhythm Sleep Treatment Sales Value Market Share by Country (2027-2032) Table 40. By-Health Company Information Table 41. By-Health Business Overview Table 42. By-Health Circadian Rhythm Sleep Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. By-Health Circadian Rhythm Sleep Treatment Product Portfolio Table 44. By-Health Recent Development Table 45. GNC Company Information Table 46. GNC Business Overview Table 47. GNC Circadian Rhythm Sleep Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. GNC Circadian Rhythm Sleep Treatment Product Portfolio Table 49. GNC Recent Development Table 50. Jameison Company Information Table 51. Jameison Business Overview Table 52. Jameison Circadian Rhythm Sleep Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Jameison Circadian Rhythm Sleep Treatment Product Portfolio Table 54. Jameison Recent Development Table 55. Koninklijke Philips Company Information Table 56. Koninklijke Philips Business Overview Table 57. Koninklijke Philips Circadian Rhythm Sleep Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Koninklijke Philips Circadian Rhythm Sleep Treatment Product Portfolio Table 59. Koninklijke Philips Recent Development Table 60. Luminette Company Information Table 61. Luminette Business Overview Table 62. Luminette Circadian Rhythm Sleep Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Luminette Circadian Rhythm Sleep Treatment Product Portfolio Table 64. Luminette Recent Development Table 65. Natrol Company Information Table 66. Natrol Business Overview Table 67. Natrol Circadian Rhythm Sleep Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Natrol Circadian Rhythm Sleep Treatment Product Portfolio Table 69. Natrol Recent Development Table 70. Nature Made (Pharmavite) Company Information Table 71. Nature Made (Pharmavite) Business Overview Table 72. Nature Made (Pharmavite) Circadian Rhythm Sleep Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Nature Made (Pharmavite) Circadian Rhythm Sleep Treatment Product Portfolio Table 74. Nature Made (Pharmavite) Recent Development Table 75. NBTY Company Information Table 76. NBTY Business Overview Table 77. NBTY Circadian Rhythm Sleep Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. NBTY Circadian Rhythm Sleep Treatment Product Portfolio Table 79. NBTY Recent Development Table 80. PEGASI Company Information Table 81. PEGASI Business Overview Table 82. PEGASI Circadian Rhythm Sleep Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. PEGASI Circadian Rhythm Sleep Treatment Product Portfolio Table 84. PEGASI Recent Development Table 85. Sleepace Company Information Table 86. Sleepace Business Overview Table 87. Sleepace Circadian Rhythm Sleep Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Sleepace Circadian Rhythm Sleep Treatment Product Portfolio Table 89. Sleepace Recent Development Table 90. Takeda Pharmaceutical Company Information Table 91. Takeda Pharmaceutical Business Overview Table 92. Takeda Pharmaceutical Circadian Rhythm Sleep Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Takeda Pharmaceutical Circadian Rhythm Sleep Treatment Product Portfolio Table 94. Takeda Pharmaceutical Recent Development Table 95. Vicks (Procter & Gamble) Company Information Table 96. Vicks (Procter & Gamble) Business Overview Table 97. Vicks (Procter & Gamble) Circadian Rhythm Sleep Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Vicks (Procter & Gamble) Circadian Rhythm Sleep Treatment Product Portfolio Table 99. Vicks (Procter & Gamble) Recent Development Table 100. Teva Pharmaceuticals Company Information Table 101. Teva Pharmaceuticals Business Overview Table 102. Teva Pharmaceuticals Circadian Rhythm Sleep Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Teva Pharmaceuticals Circadian Rhythm Sleep Treatment Product Portfolio Table 104. Teva Pharmaceuticals Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Circadian Rhythm Sleep Treatment Product Image Figure 2. Global Circadian Rhythm Sleep Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Circadian Rhythm Sleep Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Circadian Rhythm Sleep Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Drug Therapy Image Figure 8. Light Therapy Image Figure 9. Global Circadian Rhythm Sleep Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Circadian Rhythm Sleep Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Circadian Rhythm Sleep Treatment Sales Value Share by Type (2021-2032) Figure 12. Delayed Sleep Phase Syndrome (DSPS) Image Figure 13. Advanced Sleep Phase Syndrome (ASPS) Image Figure 14. Irregular Sleep-Wake Disorder (ISWD) Image Figure 15. Others Image Figure 16. Global Circadian Rhythm Sleep Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Circadian Rhythm Sleep Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Circadian Rhythm Sleep Treatment Sales Value Share by Application (2021-2032) Figure 19. Global Circadian Rhythm Sleep Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Circadian Rhythm Sleep Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Circadian Rhythm Sleep Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America Circadian Rhythm Sleep Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Circadian Rhythm Sleep Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Circadian Rhythm Sleep Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Circadian Rhythm Sleep Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Circadian Rhythm Sleep Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Circadian Rhythm Sleep Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America Circadian Rhythm Sleep Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Circadian Rhythm Sleep Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Circadian Rhythm Sleep Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Drug Therapy
  • Light Therapy
Applications
  • Delayed Sleep Phase Syndrome (DSPS)
  • Advanced Sleep Phase Syndrome (ASPS)
  • Irregular Sleep-Wake Disorder (ISWD)
  • Others
Companies covered
  • By-Health
  • GNC
  • Jameison
  • Koninklijke Philips
  • Luminette
  • Natrol
  • Nature Made (Pharmavite)
  • NBTY
  • PEGASI
  • Sleepace
  • Takeda Pharmaceutical
  • Vicks (Procter & Gamble)
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Circadian Rhythm Sleep Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Circadian Rhythm Sleep Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Circadian Rhythm Sleep Treatment Market Dynamics
  1. 2.1 Circadian Rhythm Sleep Treatment Industry Trends
  2. 2.2 Circadian Rhythm Sleep Treatment Industry Drivers
  3. 2.3 Circadian Rhythm Sleep Treatment Industry Opportunities and Challenges
  4. 2.4 Circadian Rhythm Sleep Treatment Industry Restraints
3 Circadian Rhythm Sleep Treatment Market by Company
  1. 3.1 Global Circadian Rhythm Sleep Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Circadian Rhythm Sleep Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Circadian Rhythm Sleep Treatment Company Ranking (2024-2026)
  4. 3.4 Global Circadian Rhythm Sleep Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Circadian Rhythm Sleep Treatment Company Product Type and Application
  6. 3.6 Global Circadian Rhythm Sleep Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Circadian Rhythm Sleep Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Circadian Rhythm Sleep Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Circadian Rhythm Sleep Treatment Market by Type
  1. 4.1 Circadian Rhythm Sleep Treatment Type Introduction
  2. 4.1.1 Drug Therapy
  3. 4.1.2 Light Therapy
  4. 4.2 Global Circadian Rhythm Sleep Treatment Sales Value by Type
  5. 4.2.1 Global Circadian Rhythm Sleep Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Circadian Rhythm Sleep Treatment Sales Value by Type (2021-2032)
  7. 4.2.3 Global Circadian Rhythm Sleep Treatment Sales Value Share by Type (2021-2032)
5 Circadian Rhythm Sleep Treatment Market by Application
  1. 5.1 Circadian Rhythm Sleep Treatment Application Introduction
  2. 5.1.1 Delayed Sleep Phase Syndrome (DSPS)
  3. 5.1.2 Advanced Sleep Phase Syndrome (ASPS)
  4. 5.1.3 Irregular Sleep-Wake Disorder (ISWD)
  5. 5.1.4 Others
  6. 5.2 Global Circadian Rhythm Sleep Treatment Sales Value by Application
  7. 5.2.1 Global Circadian Rhythm Sleep Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Circadian Rhythm Sleep Treatment Sales Value by Application (2021-2032)
  9. 5.2.3 Global Circadian Rhythm Sleep Treatment Sales Value Share by Application (2021-2032)
6 Circadian Rhythm Sleep Treatment Regional Value Analysis
  1. 6.1 Global Circadian Rhythm Sleep Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Circadian Rhythm Sleep Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Circadian Rhythm Sleep Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Circadian Rhythm Sleep Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Circadian Rhythm Sleep Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Circadian Rhythm Sleep Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Circadian Rhythm Sleep Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Circadian Rhythm Sleep Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Circadian Rhythm Sleep Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Circadian Rhythm Sleep Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Circadian Rhythm Sleep Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Circadian Rhythm Sleep Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Circadian Rhythm Sleep Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Circadian Rhythm Sleep Treatment Sales Value Share by Country, 2025 VS 2032
7 Circadian Rhythm Sleep Treatment Country-level Value Analysis
  1. 7.1 Global Circadian Rhythm Sleep Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Circadian Rhythm Sleep Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Circadian Rhythm Sleep Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Circadian Rhythm Sleep Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Circadian Rhythm Sleep Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Circadian Rhythm Sleep Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Circadian Rhythm Sleep Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 By-Health
  2. 8.1.1 By-Health Company Information
  3. 8.1.2 By-Health Business Overview
  4. 8.1.3 By-Health Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 By-Health Circadian Rhythm Sleep Treatment Product Portfolio
  6. 8.1.5 By-Health Recent Developments
  7. 8.2 GNC
  8. 8.2.1 GNC Company Information
  9. 8.2.2 GNC Business Overview
  10. 8.2.3 GNC Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GNC Circadian Rhythm Sleep Treatment Product Portfolio
  12. 8.2.5 GNC Recent Developments
  13. 8.3 Jameison
  14. 8.3.1 Jameison Company Information
  15. 8.3.2 Jameison Business Overview
  16. 8.3.3 Jameison Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jameison Circadian Rhythm Sleep Treatment Product Portfolio
  18. 8.3.5 Jameison Recent Developments
  19. 8.4 Koninklijke Philips
  20. 8.4.1 Koninklijke Philips Company Information
  21. 8.4.2 Koninklijke Philips Business Overview
  22. 8.4.3 Koninklijke Philips Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Koninklijke Philips Circadian Rhythm Sleep Treatment Product Portfolio
  24. 8.4.5 Koninklijke Philips Recent Developments
  25. 8.5 Luminette
  26. 8.5.1 Luminette Company Information
  27. 8.5.2 Luminette Business Overview
  28. 8.5.3 Luminette Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Luminette Circadian Rhythm Sleep Treatment Product Portfolio
  30. 8.5.5 Luminette Recent Developments
  31. 8.6 Natrol
  32. 8.6.1 Natrol Company Information
  33. 8.6.2 Natrol Business Overview
  34. 8.6.3 Natrol Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Natrol Circadian Rhythm Sleep Treatment Product Portfolio
  36. 8.6.5 Natrol Recent Developments
  37. 8.7 Nature Made (Pharmavite)
  38. 8.7.1 Nature Made (Pharmavite) Company Information
  39. 8.7.2 Nature Made (Pharmavite) Business Overview
  40. 8.7.3 Nature Made (Pharmavite) Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nature Made (Pharmavite) Circadian Rhythm Sleep Treatment Product Portfolio
  42. 8.7.5 Nature Made (Pharmavite) Recent Developments
  43. 8.8 NBTY
  44. 8.8.1 NBTY Company Information
  45. 8.8.2 NBTY Business Overview
  46. 8.8.3 NBTY Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 NBTY Circadian Rhythm Sleep Treatment Product Portfolio
  48. 8.8.5 NBTY Recent Developments
  49. 8.9 PEGASI
  50. 8.9.1 PEGASI Company Information
  51. 8.9.2 PEGASI Business Overview
  52. 8.9.3 PEGASI Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 PEGASI Circadian Rhythm Sleep Treatment Product Portfolio
  54. 8.9.5 PEGASI Recent Developments
  55. 8.10 Sleepace
  56. 8.10.1 Sleepace Company Information
  57. 8.10.2 Sleepace Business Overview
  58. 8.10.3 Sleepace Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sleepace Circadian Rhythm Sleep Treatment Product Portfolio
  60. 8.10.5 Sleepace Recent Developments
  61. 8.11 Takeda Pharmaceutical
  62. 8.11.1 Takeda Pharmaceutical Company Information
  63. 8.11.2 Takeda Pharmaceutical Business Overview
  64. 8.11.3 Takeda Pharmaceutical Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Takeda Pharmaceutical Circadian Rhythm Sleep Treatment Product Portfolio
  66. 8.11.5 Takeda Pharmaceutical Recent Developments
  67. 8.12 Vicks (Procter & Gamble)
  68. 8.12.1 Vicks (Procter & Gamble) Company Information
  69. 8.12.2 Vicks (Procter & Gamble) Business Overview
  70. 8.12.3 Vicks (Procter & Gamble) Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Vicks (Procter & Gamble) Circadian Rhythm Sleep Treatment Product Portfolio
  72. 8.12.5 Vicks (Procter & Gamble) Recent Developments
  73. 8.13 Teva Pharmaceuticals
  74. 8.13.1 Teva Pharmaceuticals Company Information
  75. 8.13.2 Teva Pharmaceuticals Business Overview
  76. 8.13.3 Teva Pharmaceuticals Circadian Rhythm Sleep Treatment Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Teva Pharmaceuticals Circadian Rhythm Sleep Treatment Product Portfolio
  78. 8.13.5 Teva Pharmaceuticals Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst